Elanco Animal Health Incorporated Stock Deutsche Boerse AG
Equities
5EA
US28414H1032
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.34 EUR | -0.13% | -1.29% | +16.02% |
May. 28 | US FDA approves Elanco's feed ingredient to cut methane emissions in dairy cows | RE |
May. 28 | Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements | MT |
Sales 2024 * | 4.49B 4.14B | Sales 2025 * | 4.69B 4.32B | Capitalization | 8.3B 7.65B |
---|---|---|---|---|---|
Net income 2024 * | -27M -24.89M | Net income 2025 * | 52M 47.95M | EV / Sales 2024 * | 2.91 x |
Net Debt 2024 * | 4.77B 4.4B | Net Debt 2025 * | 4.28B 3.94B | EV / Sales 2025 * | 2.68 x |
P/E ratio 2024 * |
-408
x | P/E ratio 2025 * |
71.9
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Elanco Animal Health Incorporated
1 day | -0.13% | ||
Current month | +20.05% | ||
1 month | +22.94% | ||
3 months | +1.71% | ||
6 months | +23.10% | ||
Current year | +16.02% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 63 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 67 | 19-03-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 15.34 | -0.13% | 0 |
24-05-27 | 15.36 | +1.36% | 0 |
24-05-24 | 15.15 | -2.77% | 0 |
24-05-23 | 15.58 | +2.06% | 0 |
24-05-22 | 15.27 | -1.72% | 0 |
Delayed Quote Deutsche Boerse AG, May 28, 2024 at 02:05 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.21% | 77.6B | |
+24.62% | 3.72B | |
-2.09% | 3.27B | |
+14.02% | 1.65B | |
-10.96% | 1.56B | |
-24.54% | 1.29B | |
-15.65% | 1.14B | |
-5.25% | 1.02B | |
-15.14% | 985M |
- Stock Market
- Equities
- ELAN Stock
- 5EA Stock